Hiroki Hamano

Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis

Yusuke Kameda, Masahiko Takahata, Shintaro Mikuni et al. · Bone · 2014 · 59 citations

Potential Therapeutic Target, Bone Disease, Translational Medicine +4

Effect of Z-360, a novel orally active CCK-2/gastrin receptor antagonist on tumor growth in human pancreatic adenocarcinoma cell lines in vivo and mode of action determinations in vitro

Daisuke Kawasaki, Yutaka Emori, Runa Eta et al. · Cancer Chemotherapy and Pharmacology · 2007 · 37 citations

Tumor Biology, Action Determinations, Oncology +9

Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) mediates periarticular bone loss, but not joint destruction, in murine antigen-induced arthritis

Tomohiro Shimizu, Masahiko Takahata, Yusuke Kameda et al. · Bone · 2015 · 37 citations

Inflammation, Rheumatology, Rheumatoid Disorder +14

Effect of polaprezinc on taste disorders in zinc‐deficient rats

Hiroki Hamano, Koji Yoshinaga, Runa Eta et al. · BioFactors · 2006 · 36 citations

Serum tau protein level serves as a predictive factor for neurological prognosis in neonatal asphyxia

Kazumasa Takahashi, Shunji Hasegawa, Shinji Maeba et al. · Brain and Development · 2013 · 35 citations

Autoimmune Disease, Predictive Factor, Neuropathology +3